GlassScriptPhysician profile
John M Owens
NPI 1033153911
$5,491.07
in general payments reported to CMS, 2019-2025
29 companies · $42.17 in 2025
The $42.17 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,013 · 2020: $338 · 2021: $281 · 2022: $291 · 2023: $286 · 2024: $241 · 2025: $42.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,267.60 | 2019 | |
| Zimmer Biomet Holdings, INC. | $607.42 | 2019-2024 | Tapestry, Stratum Foot Plating System |
| Abbott Laboratories | $402.47 | 2019-2023 | Proclaim |
| Depuy Synthes Sales INC. | $216.93 | 2019-2025 | Orthovisc, Monovisc |
| Stratus Medical, LLC | $104.96 | 2023 | Nimbus |
| Nevro Corp. | $92.86 | 2019 | |
| Horizon Therapeutics Plc | $78.31 | 2019-2020 | |
| Pacira Therapeutics, INC. | $76.57 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $73.21 | 2019-2023 | |
| Medtronic, INC. | $65.43 | 2022 | |
| Integrity Implants INC. | $64.71 | 2022 | |
| Ferring Pharmaceuticals INC. | $57.27 | 2019-2024 | Euflexxa |
| Pfizer INC. | $45.00 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $42.00 | 2019 | |
| Fidia Pharma USA INC. | $35.68 | 2019-2023 | Hymovis |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $31.26 | 2023 | Horizant |
| Kowa Pharmaceuticals America, INC. | $28.48 | 2023 | Seglentis |
| Wright Medical Technology, INC. | $27.13 | 2019 | |
| Integra Lifesciences Corporation | $19.64 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Djo, LLC | $19.28 | 2019 | |
| Heron Therapeutics, INC. | $16.64 | 2024 | Zynrelef |
| Ibsa Pharma INC. | $16.58 | 2024 | Licart, Tirosint |
| Innovation Technologies INC | $16.21 | 2021 | |
| Orthogenrx INC. | $14.74 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.68 | 2024 | Nuzyra |
| Electronic Waveform Lab, INC. | $14.57 | 2024 | |
| Collegium Pharmaceutical, INC. | $13.95 | 2019 | |
| Stimwave Technologies Incorporated | $13.79 | 2022 | |
| Smith+Nephew, INC. | $13.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.